|
|
News Headlines Research management
|
|
|
|
New China:US preclinical partnership formed
02-Jan-2008 - US-based MPI Research and China's Shanghai Medicilon have formed a joint venture in preclinical services, as they position themselves to cash in on what is a budding market sector in China.
More pharmas implicated in Iraq bribery probe
02-Jan-2008 - While GSK, AstraZeneca and Eli Lilly have hit the headlines in the UK Serious Fraud Office's (SFO) investigation into illegal bribes paid to Saddam Hussein's Iraqi regime, many more pharma firms are on the organisation's hit list.
IDM Pharma will cut jobs after Sanofi scraps melanoma collaboration
02-Jan-2008 - Sanofi-Aventis has decided to pull out of its skin cancer collaboration with IDM Pharma, leaving the Californian biopharma firm considering job cuts as a way to lower costs.
Pfizer buys CovX to bulk biologics pipeline
19-Dec-2007 - Pfizer, the world's largest pharma firm, has reached into its pockets to buy CovX, a privately-held US biotech that specialises in combining the strengths of peptides and antibodies into new drugs.
French CROs have eye on niche market
18-Dec-2007 - Two French contract research organisations (CROs) that specialise in ophthalmology have banded together to offer specialised services to this niche market.
NIH cash for new tools to unravel genome's secrets
18-Dec-2007 - The technology used to decipher an organism's gene sequence has come on in leaps and bounds this year. So much so that the US National Institutes of Health (NIH) has now released funds to create new tools to analyse this wealth of data.
Japan says Tamiflu/psychiatric link unclear
17-Dec-2007 - Any link between the antiviral Tamiflu and neuropsychiatric problems is inconclusive, according to the Japanese Government.
Biogen Idec shares nosedive after withdrawing 'for sale' sign
13-Dec-2007 - Like countless pets after every Christmas, it seems that nobody wanted Biogen Idec after all; the firm has announced it will remain independent after it 'did not receive any definitive offers to purchase the company'.
Merck confirms diabetes retreat
12-Dec-2007 - Merck Serono intends to forge ahead with severing its investment in diabetes and either sell or partner out its existing research and development (R&D) activities in this field, which it no longer feels able to compete in effectively.
Roche targets Ventana's board to force takeover
11-Dec-2007 - The latest twist in Roche's long-running bid to acquire diagnostics expert Ventana has seen the pharma giant announce it intends to elect directors to Ventana's board at its next AGM (annual general meeting).
|
|
|
|
|
